Search Press releases Keywords From To 22 Oct 2021 Disposals of own shares Read More 20 Oct 2021 UCB to license its AI technology that improves identification of Osteoporosis to ImageBiopsy Lab Read More 18 Oct 2021 Disposals of own shares Read More 16 Oct 2021 Update on U.S. FDA Review of Biologics License Application (BLA) for bimekizumab Read More 8 Oct 2021 Disposals of own shares Read More 29 Sep 2021 New BIMZELX[®]▼ (bimekizumab) two-year data in moderate to severe plaque psoriasis presented at the 30th European Academy of Dermatology and Venereology (EADV) Congress Read More Pagination First page Previous page Previous … Page 49 Page 50 Page 51 Page 52 Current page 53 Page 54 Page 55 Page 56 Page 57 … Page 53 of 63 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
